Get started
Author

Thomas Makatsoris

Observed names: Makatsoris T, Makatsoris, Thomas, T Makatsoris, T. Makatsoris, THOMAS MAKATSORIS, Th Makatsoris, Θωμάς Μακατσώρης, Μακατσώρης, Θωμάς
Observed institutions: Guy's Hospital, St Thomas' Hospital, University of Patras, Zunyi Medical University, King's College London, General University Hospital of Patras, Massachusetts General Hospital, Hellenic Cooperative Oncology Group, Affiliated Hospital of Zunyi Medical College, Hellenic Society of Medical Oncology
ORCID: 0000-0002-0927-8434
Observed ORCID: 0000-0002-0927-8434
OpenAlex ID: A5013680239
Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
2014 · Andreas Argyriou, Athanasios Kyritsis, et al. · Cancer Management and Research · 274
PDF
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes
2013 · George Pentheroudakis, Vassiliki Kotoula, et al. · BMC Cancer · 111
PDF
Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy
2006 · A. A. Argyriou, E. Chroni, et al. · Neurology · 100
Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer
2007 · Andreas A. Argyriou, Panagiotis Polychronopoulos, et al. · Acta Oncologica · 84
PDF
Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study
2013 · Evangelos Briasoulis, Gerasimos Aravantinos, et al. · BMC Cancer · 76
PDF
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study
2011 · A. Psyrri, K.T. Kalogeras, et al. · Annals of Oncology · 75
XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis
2012 · Dimitrios Pectasides, George Papaxoinis, et al. · BMC Cancer · 72
PDF
Oxaliplatin-Induced Acute-Onset Thrombocytopenia, Hemorrhage and Hemolysis
2004 · A.K. Koutras, T. Makatsoris, et al. · Oncology · 62
Improved Outcome of High-Risk Early HER2 Positive Breast Cancer With High CXCL13-CXCR5 Messenger RNA Expression
2012 · Evangelia Razis, Konstantine T. Kalogeras, et al. · Clinical Breast Cancer · 56
Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial
2012 · K. Pliarchopoulou, K. T. Kalogeras, et al. · Cancer Chemotherapy and Pharmacology · 55
Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer
2019 · Elena Fountzilas, Vassiliki Kotoula, et al. · ESMO Open · 52
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group
2007 · P.A. Kosmidis, H.P. Kalofonos, et al. · Annals of Oncology · 52
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer
2015 · Dimitrios Pectasides, Vasilios Karavasilis, et al. · BMC Cancer · 51
PDF
A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: A Hellenic Cooperative Oncology Group study
2011 · Christos A Papadimitriou, Pavlos Papakostas, et al. · BMC Medicine · 51
PDF
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study
2010 · Dimitrios Bafaloukos, Helena Linardou, et al. · BMC Medicine · 45
PDF
An MRI study of immune checkpoint inhibitor–induced musculoskeletal manifestations myofasciitis is the prominent imaging finding
2019 · Dimitrios Daoussis, Pantelis Kraniotis, et al. · Lara D. Veeken · 42
The Potential Role of TGFβ1, TGFβ2 and TGFβ3 Protein Expression in Colorectal Carcinomas
2004 · Athanassios C. Tsamandas, Dimitrios Kardamakis, et al. · Strahlentherapie und Onkologie · 38
Early-Stage Breast Cancer in the Elderly: Confronting an Old Clinical Problem
2015 · Fotinos-Ioannis D. Dimitrakopoulos, Anastasia Kottorou, et al. · Journal of Breast Cancer · 37
PDF
Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases
2013 · Alexandra V. Stavropoulou, Florentia Fostira, et al. · PLoS ONE · 35
PDF
Clinical practice guidelines for the surgical management of colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.
2016 · Evaghelos Xynos, Nikolaos Gouvas, et al. · PubMed · 34
A Phase II Study of Capecitabine Plus Oxaliplatin (XELOX): A New First-Line Option in Metastatic Colorectal Cancer
2005 · Thomas Makatsoris, Haralabos P. Kalofonos, et al. · International Journal of Gastrointestinal Cancer · 34
Vinorelbine and estramustine in androgen-independent metastatic prostate cancer
2000 · Matthew R. Smith, Donald Kaufman, et al. · Cancer · 34
PDF
EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab
2014 · Evangelia Razis, George Pentheroudakis, et al. · Journal of Cancer Research and Clinical Oncology · 33
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG)
2014 · George Pentheroudakis, Vassiliki Kotoula, et al. · BMC Cancer · 30
PDF
Impact of providing booklets about chemotherapy to newly presenting patients with cancer: a randomized controlled trial
2005 · G. Iconomou, A. Viha, et al. · Annals of Oncology · 29
PDF
Works count: 160
Citation count: 2,234
H-index: 27
I10-index: 54
Year
Topic
Type